OA
SGNT

OFI Advisors’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

OFI Advisors’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$133K Buy
8,654
+1,497
+21% +$32.4K 0.01% 1385
2015
Q2 		$174K Buy
7,157
+1,293
+22% +$31K 0.01% 1312
2015
Q1 		$136K Buy
5,864
+1,255
+27% +$33.2K 0.01% 1406
2014
Q4 		$116K Buy
4,609
+479
+12% +$14.1K 0.01% 1433
2014
Q3 		$128K Buy
+4,130
New +$112K 0.01% 1360

Other funds holding SGNT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OFI Advisors's SGNT Position: Q3 2015 in Review

OFI Advisors increased its SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) stake by 21% in Q3 2015, buying an estimated $32.4K and bringing the position to 8,654 shares worth $133K. The position accounts for 0.01% of the portfolio, ranked #1385.

OFI Advisors first reported a position in SGNT in Q3 2014 and has held it in 5 quarters since. The position peaked at $174K in Q2 2015. 127 funds tracked by Wall St. Rank hold SGNT as of Q3 2015.

  • OFI Advisors held 8,654 shares of SAGENT PHARMACEUTICALS INC COM STK (DE) worth $133K as of Q3 2015.
  • OFI Advisors bought 1,497 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2015, an estimated $32.4K.
  • SAGENT PHARMACEUTICALS INC COM STK (DE) made up 0.01% of OFI Advisors's portfolio in Q3 2015, its #1385 holding.
  • OFI Advisors first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2014 and has held it in 5 quarters since.
  • OFI Advisors's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $174K in Q2 2015.
  • 127 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.